New Alzheimer's Drug Is First to Show It Slows Disease. But It's Facing a Rocky Rollout.

Once patients have cleared those hurdles, they have to start infusions, a new experience for most Alzheimer's doctors, according to Allison Lapins, a neurologist at Northwestern University Feinberg School of Medicine. New Alzheimer's Drug Is First to Show It Slows Disease. (Bloomberg) -- Eisai Co.'s breakthrough Alzheimer's drug - the first to show it slows the brain-destroying disease - is facing a rocky rollout as doctors grapple with logistical issues, insurance uncertainties and complicated safety testing requirements. [Extracted from the article]